125
Participants
Start Date
October 27, 2021
Primary Completion Date
December 2, 2024
Study Completion Date
March 31, 2027
Acasunlimab
Acasunlimab will be administered intravenously (IV)
Pembrolizumab
Pembrolizumab will be administered IV
Florida Cancer Center, St. Petersburg
Florida Cancer Specialists - FCS South, Fort Myers
Henry Ford Cancer Institute, Detroit
Cancer & Hematology Centers of Western Michigan CHCWM P.C., Grand Rapids
Medical College of Wisconsin, Milwaukee
St. Joseph Heritage Healthcare, Santa Rosa
Institut Bergonie, Bordeaux
Hopital Morvan CHU de Brest, Brest
Hopital Charles Nicolle Chu Rouen, Rouen
Hopital dInstruction Des Armees Begin, Saint-Mandé
Institut de Cancerologie Strasbourg Europe (ICANS), Strasbourg
Hôpital Foch, Suresnes
Gustave Roussy, Villejuif
Med.Hochschule Hannover Klinik für Pneumologie, Hanover
Universitatsklinik Giessen und Marburg Standort Giessen, Hessen
LKI Lungenfachklinik Immenhausen, Immenhausen
Department of Internal Medicine II, Regensburg
Azienda Ospedaliera Universitaria Policlinico G Rodolico San Marco, Catania
IRCCS Istituto Europeo di Oncologia, Milan
UOC Oncoematologia AOU L.Vanvitelli, Napoli
La Maddalena SPA, Palermo
IFO Regina Elena, Roma
Netherlands Cancer Institute, Amsterdam
VU University Medical Center, Amsterdam
Leids Universitair Medisch Centrum, Leiden
Erasmus MC, Rotterdam
Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc, Olsztyn
Med Polonia Sp. z o.o., Poznan
Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw
Centro Clinico Champalimaud, Lisbon
Centro Hospitalar Universitário do Porto - Hospital de Santo Antonio, Porto
Hospital Universitari Vall dHebron, Barcelona
Clinica Universidad de Navarra CUN, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario Fundacion Jimenez Diaz, Madrid
MD Anderson Cancer Center, Madrid
Hospital Universitario Virgen de la Victoria, Málaga
Clinica Universidad de Navarra, Pamplona
Fundacion Instituto Valenciano de Oncologia, Valencia
Hospital Clinico Universitario de Valencia, Valencia
Cheltenham General Hospital, Cheltenham
The Christie Hospital, Manchester
Lead Sponsor
Merck Sharp & Dohme LLC
INDUSTRY
Genmab
INDUSTRY